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41 genes, 16 pairs of SNPs were implicated in the develop-
ment of collaterals with the FDR of 0.19. Nine SNPs were 
found to potentially have main effects on collateral forma-
tion. Two sets of coupling haplotypes that predispose to col-
lateral formation were suggested.  Conclusions: These find-
ings suggest that collateral formation may arise from the 
interactions between several SNPs in inflammatory response 
related genes, which may represent targets in future studies 
of collateral formation. This may enhance developing strate-
gies for risk stratification and therapeutic stimulation of ar-
teriogenesis.  Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 Formation of collateral circulation is an endogenous 
response to occlusive atherosclerotic arterial disease, and 
could be seen as a natural escape mechanism by re-rout-
ing blood to areas jeopardized by critical blood flow  [1, 
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 Abstract 
 Objectives: Formation of collateral circulation is an endog-
enous response to atherosclerosis, and is a natural escape 
mechanism by re-routing blood. Inflammatory response-
related genes underlie the formation of coronary collaterals. 
We explored the genetic basis of collateral formation in man 
postulating interaction networks between functional Single 
Nucleotide Polymorphisms (SNPs) in these inflammatory 
gene candidates.  Methods: The contribution of 41 genes as 
well as the interactions among them was examined in a co-
hort of 226 coronary artery disease patients, genotyped for 
54 candidate SNPs. Patients were classified to the extent of 
collateral circulation. Stepwise logistic regression analysis 
and a haplotype entropy procedure were applied to search 
for haplotype interactions among all 54 polymorphisms. 
Multiple testing was addressed by using the false discovery 
rate (FDR) method.  Results: The population comprised 84 
patients with and 142 without visible collaterals. Among the 
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2] . In ischemic heart disease, collaterals potentially im-
prove prognosis  [3] , by preserving myocardial function 
and perfusion  [4, 5] and reducing infarct size  [6, 7] . Un-
derstanding the genomic program leading to collateral 
formation may be of fundamental importance to improve 
diagnosis, treatment and prevention of coronary artery 
diseases. Despite its importance, currently the determi-
nants and mechanisms of collateral artery formation in 
man are incompletely understood. A major trigger in the 
etiology of collateral formation is chronic ischemia and 
the extent of atherosclerotic burden. However, in the 
presence of a certain fixed degree of stenosis  [8] or even 
sudden occlusion  [9] , there is ample evidence to support 
a large variation between individuals in extent of collat-
eral formation. This variation is only partly attributable 
to clinical characteristics. Seminal studies on etiology of 
neovascularization  [10] have shown that several bio-
chemical pathways underlie formation of collaterals. No-
tably the processes occurring are the sprouting of new 
capillaries (angiogenesis)  [11] and the maturation of pre-
cursor collaterals (arteriogenesis)  [12] involving remod-
elling by monocyte activation and inflammation. Ac-
cordingly, the use of immunosuppressants in coronary 
stents is associated with less functional collateral circula-
tion  [13] . A recent study seeking a genomic model of ar-
teriogenesis using microarray data for temporal func-
tional analyses of gene expression in mice showed that 
inflammatory response-related genes comprised the larg-
est cluster among the up-regulated genes  [14] . These fas-
cinating insights in other species support a genetic com-
ponent in the formation of collaterals, where the action 
of multiple genes in inflammatory response pathways 
may be required. Once a set of candidate genes has been 
identified, a number of potentially modifying genetic 
variants may exist in these genes. These genetic variants, 
in concert with specific gene-environment effects and 
gene-gene interactions, may play an important role in the 
pathogenesis of collateral formation. For example, the ef-
fect of an allele of a certain SNP at a locus may be medi-
ated by specific alleles on other loci. Therefore, any single 
gene or locus based study may not be sufficient for iden-
tification of the determinants or modifying factors in the 
development of collaterals.
 In the current study, we postulated that the genetic 
basis of collateral formation is comprised of interaction 
networks between functional SNPs in several inflamma-
tory genes. We therefore analysed genotypes of patients 
with coronary artery disease, using a panel of polymor-
phisms in 41 genes that are related to various inflamma-
tory processes. We first analyze the data with a stepwise 
logistic regression  [15] . Then we conduct a search for lo-
cus-locus interactions through use of the haplotype en-
tropy procedure  [16] .
 Methods 
 Study Population 
 The source population for the present study originated from 
the Second Manifestations of Arterial Disease (SMART) Study, 
an ongoing prospective cohort study at the University Medical 
Centre Utrecht designed to establish the prevalence of concomi-
tant arterial diseases and risk factors for atherosclerosis in a high-
risk population  [17] . The local ethics committee approved the 
study, and all participants gave their written informed consent. 
Clinical information was obtained using a standardized health 
questionnaire. DNA was extracted from buffycoats using an ex-
traction kit (QIagen biosystems) and stored at –80 ° C. For the 
present cross-sectional study, based on a case-cohort study inves-
tigating determinants and prognostic value of coronary collateral 
formation, 226 consecutive patients referred for revascularization 
and included between January 1998 and July 2002 were enrolled. 
All patients had symptoms of stable angina pectoris at the time of 
enrollment.
 Angiographic Assessment 
 Coronary angiograms originated from the participants’ diag-
nostic work-up preceding a scheduled coronary intervention at 
the UMC Utrecht. Two experienced observers, blinded to all pa-
tient characteristics, independently reviewed the angiograms. 
The Rentrop classification  [18] was used to determine the extent 
of collateral formation (grade 0: no filling of collateral vessels; 
grade 1: filling of collateral vessels without any epicardial filling 
of the recipient artery; grade 2: partial epicardial filling by col-
lateral vessels of the recipient artery; and grade 3: complete epi-
cardial filling by collateral vessels of the recipient artery). The 
patients were assigned to either the case group (with visible col-
laterals, i.e., Rentrop score ≥1) or the control group (without vis-
ible collaterals, i.e., Rentrop score = 0). Severity of coronary artery 
disease was defined (single, two, or three vessel disease) as the 
degree of the most severe stenosis (50–90, 90–99, or 100% steno-
sis). A 50% diameter reducing stenosis was regarded as significant 
 [19] .
 Genotyping 
 Genes involved in various inflammatory processes were con-
sidered as candidates. A SNP assay designed by Roche Molecular 
Systems was used in this study. This assay for detecting bi-allelic 
variants contained mostly coding non-synonymous SNPs previ-
ously reported in genes involved in inflammatory processes. Each 
DNA sample was amplified using two multiplex polymerase 
chain reactions, and the alleles were genotyped simultaneously 
using an array of immobilized, sequence-specific oligonucleotide 
probes as described elsewhere  [20] . The assay was composed of a 
panel of 51 SNPs, described previously  [21, 22] and listed in  ta-
ble 1 . One of them [GC(C35717A)] was not used in the analysis 
afterward because the poor quality of genotyping on this locus. 
In addition, four extra polymorphisms (Haptoglobin(Hp2FS 1
 Hp1S), MCP1(A-2518G), VEGF(G405C), TLR4(A896G)) were 
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Block and SNP (symbol) Location Gene name rs# OMIM #
1:00
T707C [V1] 1p32-p31 VCAM1 1041163 192225
A153C [V2] 1q22-q25 SELE 5361 131210
G40A [V3] 1q21-24 SELP 6131 173610
G75271T [V4] 1q21-24 SELP 6133
C8700A [V5] 1q31-32 IL10 1800872 124092
2:00  
T549C [V6] 2q12-21 IL1A 1800587 147760
C1423T [V7] 2q14 IL1B 16944 147720
C4336T [V8] 2q14 IL1B 1143634
C875T [V9] 2q33 CTLA4 5742909 123890
A1241C [V10] 2q33 CTLA4 231775
3:00
G46295A [V11] 3p21 CCR2 1799864 601267
C320T [V12] 3p21.3 CCR3 5742906 601268
Wt/580–611 [V13] 3p21 CCR5 333 601373
G59029A [V14] 3p21 CCR5 1799987
G482A [V15] 3p24-26 IL5RA 2290608 147851
4:00
G35706 [V16] 4q12-13 GC 7041 139200
5:00
C582T [V17] 5q23-31 IL4 2243250 147780
C4045T [V18] 5q31 IL13 1295686 147683
A1633G [V19] 5q31-32 ADRB2 1042713 109690
C1666G [V20] 5q31-32 ADRB2 1042714
C2078T [V21] 5q31-32 ADRB2 1800888
C2232T [V22] 5q22-32 CD14 2569190 158120
C883A [V23] 5q31 TCF7 5742913 189908
A383T [V24] 5q31.1 TCF7 244656 189908
C4244T [V25] 5q31-35 IL9 2069885 146931
T2600C [V26] 5q31.1 CSF2 25882 138960
A620C [V27] 5q35 LTC4S 730012 246530
6:00
G405C [V28] (*) 6p12 VEGF 192240 192240
A1069G [V29] 6p21.3 LTA 909253 153440
G3787A [V30] 6p21.3 TNF 1800629 191160
G3857A [V31] 6p21.3 TNF 361525
7:00
G589C [V32] 7p15-21 IL6 1800796 147620
G987C [V33] 7p15-21 IL6 1800795  
A498G [V34] 7q35-36 NOS3 1800779 163729
G7002T [V35] 7q35-36 NOS3 1799983
8:00
A896G [V36] (*) 9q32-33 TLR4 603030 603030
A2416G [V37] 9q32-34 C5 187611 120900
9:00
G880A [V38] 10q11.1 SDF1 1801157 600835
10:00
A7297G [V39] 11q13 FCERB1 569108 147138
G587A [V40] 11q11–ter UGB 3741240 192020
Table 1. SNPs used in the present study
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genotyped separately using Restriction Fragment Length Poly-
morphism assays. This gives 54 polymorphisms totally. These ge-
netic variants were numbered [V1 through V54] and grouped into 
blocks according to chromosomes where they were located (see 
 table 1 ).
 Statistical Analysis
Search for Main Factors 
 To detect main effects of individual genes, we conducted a lo-
gistic regression analysis on the genotype data following the step-
wise approach of Cordell and Clayton  [15] . We took the Rentrop 
score as a response variable and the polymorphisms as covariates. 
The covariate will take value of –0.5 if the genotype at the corre-
sponding locus is 0 (homozygous with wild type), and 0.5 if the 
genotype is 1 (homozygous with rare variant), or 2 (heterozy-
gous), or missing. We set the threshold p value of 0.05 in the step-
wise selection of these polymorphisms.
 Search for Haplotype Interactions 
 As pointed out by Zhang et al.  [16] , the above logistic regres-
sion approach may be unable to detect the contributions of hap-
lotype interactions to collateral formation. This is because the 
logistic regression approach allows only for testing genotype in-
teractions; possibly miss the interactions reflected only at the 
haplotype level. To contend with this disadvantage, we applied the 
haplotype entropy procedure of Zhang et al.  [16] to search for in-
teracting pairs of polymorphisms between and within 14 blocks 
defined in  table 1 that predispose to collateral formation. This 
was done in two stages. In the first stage we searched for the in-
teractions between and within chromosome blocks in each of two 
individual groups by performing a permutation procedure. The 
significance of the results were shown by both p values and Z-
scores of Zhang et al.  [16] .
 In the second stage, the interactions predisposing collaterals 
were then found by contrasting the interaction patterns observed 
for cases with the interaction patterns for controls. In this stage, 
we set the thresholds ( p 1 ,  p 2 ) for the observed p values. If the p 
value of the patients without visible collaterals was larger than  p 2 
and the p value of the patients with visible collaterals was less than 
or equal to  p 1 , we assumed an up interaction associated with col-
laterals. This infers that, in contrast to the patients without visible 
collaterals, there is a significant interaction between two chromo-
some blocks under consideration in the patients with visible col-
laterals. If the p value of the patients with visible collaterals was 
larger than  p 2 and the p value of the patients without visible col-
laterals was less than or equal to  p 1 , we assumed a down interac-
tion associated with collaterals. This infers that, in contrast to the 
patients without visible collaterals, there is no significant interac-
tion between two chromosome blocks under consideration in the 
patients with visible collaterals. Zhang et al.  [16] did a simulation 
study on how to set the thresholds ( p 1 ,  p 2 ). Here, we applied two 
settings of thresholds, notably [0.02, 0.15] for stronger interac-
tions and [0.05, 0.15] for detecting relatively weaker interactions. 
The opting for these thresholds for p values was validated by the 
simulation in Zhang et al.  [16] .
 The search for interacting SNP pairs above involves several 
hundreds of the tests. There will be a potential impact of multiple 
testing on the false positive error. Since these tests are highly cor-
related, a conventional Bonferroni adjustment for multiple testing 
would be too conservative. To address this issue, we adopted FDR, 
Table 1 (continued)
Block and SNP (symbol) Location Gene name rs# OMIM #
11:00
T12022C [V41] 12q13.1 VDR 2228570 601769
G45082A [V42] 12q13.1 VDR 1544410
12:00
Hp2FS>Hp1S [V43]* 16q22.1 Haptoglobin (Hp) 140100
A398G [V44] 16p11.2-12.1 IL4R 1805010 147781
T1682C [V45] 16p11.2-12.1 IL4R 1805015
A1902G [V46] 16p11.2-12.1 IL4R 1801275
13:00
A-2518G [V47]* 17q11.2-12 MCP1 158105 158105
G361A [V48] 17q21.1-21.2 SCYA11 3744508 601156
C231T [V49] 17q11.2-12 NOS2A 1137933 163730
G1169A [V50] 17q21.1-21.2 SCYA11 4795895 601156
14:00
A120T [V51] 19p13.2 ICAM1 5491 147840
G657A [V52] 19p13.2 ICAM1 1799969
C629T [V53] 19q13.1 TGFB1 1800469 190180
C364G [V54] 19p13.2-13.3 C3 2230199 120700
* These SNPs were genotyped using Restriction Fragment Length Polymorphism assays.
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a widely used significance measure for the overall error rate in 
multiple testing  [23] . FDR is defined by the expected proportion 
of false positives among the tests called significant. Here we ad-
opted a truncated Z-score mixture model based procedure (un-
published report, Zhang and Liang 2007) to identify subsets of the 
significant tests with the pre-specified FDR values. In the proce-
dure the truncated Z-scores are assumed to follow a mixture 
model,
f(z) = 0 f0(z) + (1 – 0) f1 (z),
 where   0 is the probability that a null hypothesis is true, and  f 0 
and  f 1 are fitted by the exponential power mixtures (unpublished 
report, Zhang and Liang 2007). Note that the device of truncation 
has been used to deal with the potential outliers in the test scores. 
The so-called Expectation-Conditional-Maximisation algorithm 
are then applied to calculate estimators,   ˆ  0 and  Fˆ  0 , of   0 and  F 0 , 
where  F 0 is the distribution function of  f 0 . The FDR can be esti-















 where  N is the number of the test scores and  # { z i :  z i  6  z 0 } denotes 
the number of tests with test score larger than or equal to the 
threshold  z 0 . We select the threshold  z 0 so that  F ˆdr ( z 0 ) reach the 
pre-specified FDR value. 
 Haplotyping the Interaction Networks 
 To explain the potential mechanism behind these interaction 
networks, collateral-predisposing coupling haplotypes were iden-
tified within these networks. This requires addressing potential 
over-fitting, since the dimension of space of the candidate haplo-
types is much larger than the sample size. To tackle this problem 
we first expanded the above networks by including those SNPs 
which are in linkage disequilibrium with some SNPs in the above 
networks ( table 2 ). Then we haplotyped parts of a network (usu-
ally including 3 or 4 SNPs) and merged these parts in an agglom-
erative way. We stopped this merging process if no of the resulting 
haplotypes are approximately equally frequent in the control 
group and in the case group. Note that this strategy is based on 
the assumption that among many haplotype combinations, only 
a few are believed to be really coupling in both groups (these hap-
lotype combinations are called base-line haplotype combina-
tions). To show the strength of the evidence that a coupling hap-
lotype combination is associated with collateral formation, we 
calculated the odds ratio of cases (Rentrop  6 1) relative to controls 
(Rentrop = 0). More specifically, the odds ratio  OR =  (n 11  *  n 22 )/
( n 21  *  n 12 ), where  n 11 and  n 12 are the frequencies of the baseline 
haplotype combination in the two groups while  n 21 and  n 22 are 
the frequencies of a haplotype combination in the two groups. 
The 95% CI for the odds ratio was calculated based on Woolf ’s 
method  [24] .
 Results 
 Angiographic Assessment 
 Collaterals were visible in 84 (37%) of the 226 partici-
pants included in the analyses. This prevalence of collat-
erals agreed with other similar populations previously 
described  [25] in our centre. Multi-vessel disease and 
smoking occurred more often in the group with visible 
collateral than in the group without visible collateral (see 
 table 3 ).
 Search for Main Risk Factors 
 The stepwise selection procedure on the genotype data 
provided only marginal suggestion for major effects of 
9 polymorphisms on collateral formation (with 0.025  ! 
p values  ! 0.05). These polymorphisms were located in 
9 genes listed in  table 4 .
Block pair/chrom. loc.
SNP pair/gene pair
Visible collaterals Invisible collaterals
p value Z score p value Z score
[3,6]/[3,6]
[V11:V30]/[CCR2:TNF] 0.015 –0.643 0.005 –6.234
[1,1]/[1,1]
[V2:V3]/[SELE:SELP] 0.000 18.538 0.000 –8.668
[2,2]/[2,2]
[V6:V8]/[IL1A:IL1B] 0.000 –8.153 0.000 –15.940
[V7:V8]/[IL1B:IL1B] 0.005 –0.796 0.040 –2.208
[V9:V10]/[CTLA4:CTLA4] 0.000 –5.189 0.005 –4.106
[3,3]/[3,3]
[V11:V14]/[CCR2:CCR5] 0.000 –0.725 0.040 –2.956
[V13:V14]/[CCR5:CCR5] 0.000 –0.818 0.000 –5.111
[5,5]/[5,5]
[V19:V20]/[ADRB2:ADRB2] 0.000 –24.281 0.000 –12.471
Table 2. Pairs of SNPs in linkage
disequilibrium in both the case and
control groups (with and without visible 
collateral respectively)
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 Search for Haplotype Interaction 
 To apply the haplotype entropy procedure  [16] to the 
pairs of polymorphisms between and within 14 blocks 
defined in  table 1 , we first set the thresholds for the p val-
ues at the level of ( p 1 ,  p 2 ) = (0.02, 0.15). Consequently, 
down interaction was observed in 9 pairs of polymor-
phisms [V1:V14, V4:V11, V14:V28, V16:V38, V29:V49, 
V30:V49, V37:V40, V18:V25, V23:V26]. Up interaction 
was observed in 4 pairs of polymorphisms [V10:V38, V13:
V41, V16:V26, V28:V30]. Setting the thresholds at the lev-
el of ( p 1 ,  p 2 ) = (0.05, 0.15), we detected 3 additional down-
interacting [V 22:V 37,  V 2 :V 5,  V 48 :V 50]  and 6 additional 
up-interacting pairs [V14:V29, V15:V29, V17:V23, V17:
V26, V33:V35, V43:V44]. See  table 5 for more details. 
These interactions might influence the formation of col-
laterals via interaction networks as schemed in  figure 2 , 
which also displays Linkage Disequilibrium between 
pairs of SNPs in both the cases and controls (detected us-
ing the same procedure).
 To address the issue of false discovery in the above 
findings and select the statistically validated interactions, 
we applied the FDR controlling procedure of Zhang and 
Liang to the Z-scores obtained in the multiple tests above. 
We identified two subsets of interacting pairs with two 
pre-specified FDR values. At the FDR value of 0.056, we 
identified 8 significant up- or down-interacting SNP 
pairs: [V1:V14, V4:V11, V10:V38, V14:V28, V37:V40, V18:
V25, V28:V30, and V43:V44]. Among these pairs 0.056  ! 
8  ; 0.44 pairs are expected to be false positive. If we relax 
the FDR value to 0.19, we found 16 up- or down-interact-
ing SNP pairs: [V1:V14, V4:V11, V10:V38, V14:V28, V14:
V29, V15:V29, V22:V37, V37:V40, V2:V5, V17:V23, V17:
V26, V18:V25, V23:V26, V28:V30, V33:V35, and V43:V44]. 
Among the above 16 pairs of interacting SNPs, 0.19  !
 16  ; 3 pairs are expected to be false positive.
 Table 3 indicates that the case and control groups in 
the study were approximately matched for all baseline 
features, except those related to smoking and multi-vessel 
disease (disease severity). To assess the possible con-








Age, years 5789.5 5889 0.5705
Male 72 (86) 113 (80) 0.3279
Clinical conditions
Systemic hypertension 25 (30) 62 (44) 0.0531
Hyperlipidemia 71 (85) 117 (82) 0.8184
Diabetes 23 (27) 23 (16) 0.0647
Alcohol consumption 69 (82) 117 (82) 1
Smoking 32 (38) 31 (22) 0.0131
Previous MI 41 (49) 54 (39) 0.1336
Duration since MI until PTCA, years** 1 (0-19) 1 (0-8)
Previous PTCA and/or CABG 26 (31) 47 (33) 0.8522
Multi-vessels disease 47 (56) 42 (30) <0.0001
* Number presented in count (%) or mean 8 standard deviation. MI = myocardial 
infarction; PTCA = percutaneous transluminal coronary angioplasty; CABG = coronary 
artery bypass grafting.
** Number presented in median (10–90% percentiles). The p values were calculated 
based on the two-sample test for proportions or for means.
Table 3. Main characteristics of study
subjects (n = 226)*





IL1A V6 (T549C) 1 (TT) 0.0325
VDR V42 (G45082A) 0 (AA) 0.0488
SCYA11 V48 (G361A) 1 (GG) 0.0278
CD14 V22 (C2232T) 1 (CC) 0.0351
TCF7 V23 (C883A) 0 (AA) 0.0474
SDF1 V38 (G880A) 0 (AA) 0.0443
VEGF V28 (G405C) 1 (GG) 0.0426
LTC4S V27 (A620C) 0 (CC) 0.0470
NOS3 V34 (A498G) 0 (GG) 0.0360
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tion, we excluded the subjects who have the smoking hab-
it or multi-vessel disease and performed the haplotype 
entropy procedure on the remaining 99 subjects (75 con-
trols and 24 cases). The results, summarised in  table 6 , 
show a reduction in the number of significant interacting 
SNP pairs. Only 5 of the 16 previously identified interac-
tions remain significant with the FDR less than 0.19: 
[V14:V28, V15:V29, V37:V40, V17:V23, V18:V25, and V23:
V26]. Note that the testing power of the haplotype en-
tropy procedure is decreasing in the sample size. This im-
plies that the above reduction might be caused by the 
small size of the remaining case group. 
Table 5. Haplotype interactions that may influence the formation of collaterals based on all subjects
Block pair/chrom. loc.
or SNP pair/gene pair
No visible collaterals Visible collaterals Interaction FDR level
p value Z score p value Z Score 0.056 0.19
[1,3]/[1,3] 0.005 –2.106 0.110 –1.266 down no yes
[V1:V14]/[VCAM1:CCR5] 0.010 –2.798 0.580 0.216 down yes yes
[V4:V11]/[SELP:CCR2] 0.005 –3.210 0.980 –0.080 down yes yes
[2,9]/[2,10] 0.925 1.263 0.010 –3.073 up
[V10:V38]/[CTLA4:SDF1] 0.430 0.052 0.000 –4.395 up yes yes
[3,6]/[3,6] 0.000 –3.216 0.350 –0.299 down yes yes
[V14:V28]/[CCR5:VEGF] 0.015 –2.541 0.960 0.837 down yes yes
[V14:V29]/[CCR5:LTA] 0.985 1.540 0.030 –2.156 up no yes
[V15:V29]/[IL5RA:LTA] 0.833 –0.149 0.030 –2.114 up no yes
[3,11]/[3,12] 0.655 0.552 0.045 –2.017 up no no
[V13:V41]/[CCR5:VDR] 0.670 0.414 0.015 –0.489 up no no
[4,5]/[4,5] 0.525 0.081 0.000 –2.104 up no no
[V16:V26]/[GC:CSF2] 0.433 –0.324 0.005 –0.886 up no no
[4,9]/[4,10] 0.000 –0.756 0.170 –0.299 down no no
[V16:V38]/[GC:SDF1] 0.020 –0.725 0.215 –0.330 down no no
[4,12]/[4,16] 0.965 1.897 0.020 –2.110 up no no
[5,8]/[5,9] 0.940 1.579 0.150 –0.962 no no
[V22:V37]/[CD14:C5] 0.045 –1.939 0.980 1.540 down no yes
[6,13]/[6,17] 0.055 –1.658 0.725 0.576 no no
[V29:V49]/[LTA:NOS2A] 0.008 –0.817 0.763 0.716 down no no
[V30:V49]/[TNF:NOS2A] 0.018 –0.513 0.373 –0.384 down no no
[8,10]/[9,11] 0.085 –1.506 0.750 0.648 no no
[V37:V40]/[C5:UGB] 0.020 –2.722 0.480 0.114 down yes yes
[1,1]/[1,1]
[V2:V5]/[SELE:IL10] 0.040 –1.950 0.465 –0.165 down no yes
[5,5]/[5,5]
[V17:V23]/[IL4:TCF7] 0.995 1.453 0.045 –2.208 up no yes
[V17:V26]/[IL4:CSF2] 0.455 0.011 0.030 –2.124 up no yes
[V18:V25]/[IL13:IL9] 0.005 –3.061 0.765 0.457 down yes yes
[V23:V26]/[TCF7:CSF2] 0.015 –2.335 0.410 –0.778 down no yes
[6,6]/[6,6]
[V28:V30]/[VEGF:TNF] 0.210 –0.763 0.000 –12.493 up yes yes
[7,7]/[7,7]
[V33:V35]/[IL6:NOS3] 0.720 0.486 0.045 –2.295 up no yes
[12,12]/[16,16]
[V43:V44]/[Hp:IL4R] 0.525 0.155 0.040 –2.079 up yes yes
[13,13]/[17,17]
[V48:V50]/[SCYA11:SCYA11] 0.030 –0.911 0.525 –0.104 down no no
The SNP/gene pairs which showed significant up- or down-interactions via the contrast of the interaction patterns between the 
group with visible collaterals and that without visible collaterals. The significance of these interactions was measured by the haplo-
type-entropy based p values and Z values [16].
‘yes’ = Stands for passing the FDR criteria.
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 We also conducted the search for block-level interac-
tions among these 14 unlinked blocks, using the above 
entropy method. The search was performed on the case 
and control groups separately. The p values for these two 
groups were compared by plotting them in graphs, as 
shown in  figure 1 . These block pairs were selected by use 
of the thresholds for the p values at the level of ( p 1 ,  p 2 ) = 
Table 6. Haplotype interactions that may influence the formation of collaterals based on non-smoking and non 
multi-vessel diseased subjects
Block pair/chrom. loc.
or SNP pair/gene pair
No visible collaterals Visible collaterals  Interaction
p value Z score p value Z score
[1,3]/[1,3]
[V1:V14]/[VCAM1:CCR5] 0.125 –1.211 0.495 –0.131
[V4:V11]/[SELP:CCR2] 0.060 –2.573 1.000 0.411
[2,9]/[2,10]
[V10:V38]/[CTLA4:SDF1] 0.270 –0.648 0.110 –1.961
[3,6]/[3,6]
[V14:V28]/[CCR5:VEGF] 0.005 –2.900 0.845 0.424 down
[V14:V29]/[CCR5:LTA] 0.995 1.733 0.405 –0.140 
[V15:V29]/[IL5RA:LTA] 0.930 0.073 0.975 0.889
[3,11]/[3,12]
[V13:V41]/[CCR5:VDR] 0.745 0.5823 0.035 –3.613 up
[4,5]/[4,5]
[V16:V26]/[GC:CSF2] 0.510 –0.107 0.305 –0.588
[4,9]/[4,10]
[V16:V38]/[GC:SDF1] 0.205 –0.409 0.410 –0.109
[5,8]/[5,9]
[V22:V37]/[CD14:C5] 0.605 0.536 0.455 0.127
[6,13]/[6,17]
[V29:V49]/[LTA:NOS2A] 0.015 –0.772 0.620 0.617 down
[V30:V49]/[TNF:NOS2A] 0.555 –0.439 0.495 –0.408
[8,10]/[9,11]
[V37:V40]/[C5:UGB] 0.010 –2.844 0.990 1.164 down
[1,1]/[1,1]
[V2:V5]/[SELE:IL10] 0.710 0.369 0.135 –0.768
[5,5]/[5,5]
[V17:V23]/[IL4:TCF7] 0.990 1.789 0.000 –10.68 up
[V17:V26]/[IL4:CSF2] 0.390 –0.480 0.200 –0.674
[V18:V25]/[IL13:IL9] 0.010 –3.162 0.155 –1.071 down
[V23:V26]/[TCF7:CSF2] 0.010 –2.877 0.665 –0.660 down
[6,6]/[6,6]
[V28:V30]/[VEGF:TNF] 0.990 1.175 0.905 0.980
[7,7]/[7,7]
[V33:V35]/[IL6:NOS3] 0.905 1.089 0.645 0.383
[12,12]/[16,16]
[V43:V44]/[Hp:IL4R] 0.595 0.298 0.070 –2.346
[13,13]/[17,17]
[V48:V50]/[SCYA11:SCYA11] 0.115 –1.938 0.705 –0.207
The SNP/gene pairs which showed significant up- or down-interactions via the contrast of the interaction 
patterns between the group with visible collaterals and that without visible collaterals. The significance of these 
interactions was measured by the haplotype-entropy based p values and Z values [16].
 Fig. 1. The p values of testing the interactions of blocks 1–14 with 
the other blocks, for the subjects with and without visible collater-
als, respectively. The dots are for the subjects with visible collater-
als and the lines with crosses are for the subjects without visible 
collaterals. The two straight lines are for the upper and lower 
thresholds (that is, 0.15 and 0.01) of p values respectively. 
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(0.01, 0.15). We obtained 4 interacting block pairs on the 
chromosome pairs [2, 10], [3, 6], [4, 5], and [4, 10]. See 
 t able 5. Among these selected pairs of blocks, [3, 6] and 
[4, 10] are down-interacting. The up-interaction pairs 
were on the chromosome pairs [2, 10] and [4, 5]. These 
interacting pairs have passed the FDR criteria (i.e., FDR 
being less than 0.19).
 Finally, we adopted the strategy mentioned in the last 
section to find the coupling haplotypes in the networks 
as follows. The first set of coupling haplotypes, related to 
the gene/SNP combination VCAM1-SELP-CCR2-CCR5-
IL5RA-VEGF-LTA-TNF-NOS2A/(V1-V4-V11-V14-V15-
V28-V29-V30-V49) include: TGGGGGAGC, CGGAG-
CAGC, TGGGGCAGC, TGGGGGAGT, TGGAAGAGC. 
The second set of coupling haplotypes, related to the 
gene/SNP combination  GC-IL4-TCF7-CSF2/(V16-V17-
V23-V26), include: TCCT, GCAC, GCAT, TTCT. See  ta-
ble 7 for the details.
 Discussion 
 Implications of the Results 
 In the present study, 54 genetic variants in candidate 
genes and their interactions were studied as determinants 
of collateral formation in the context of patients with cor-
onary artery disease. In the first stage, the effects of 9 
variants were detected using a conventional approach by 
running a stepwise logistic regression. In the second 
stage, a search for haplotype interactions using the hap-
lotype entropy procedure put forward a set of 28 genes 
involved in collateral formation, including a network of 
22 SNP-SNP hypothesized interactions. Twelve of the hy-
pothesized interactions are down-interactions and the 
remaining 10 are up-interactions. The up-interactions 
would suggest that these interactions lead to a suscepti-
bility to collateral formation, whereas the down-interac-
tions could imply that the interactions may reduce the 
development of collaterals. Two sets of coupling haplo-
types have been suggested. The overall multiple testing 
error rate has been addressed by use of the FDR control-
ling procedure of Zhang and Liang. In particular, 16 of 
these 22 interactions, where 24 genes were involved, have 
been found to have the estimated FDR value of 0.19. They 
are [VCAM1, CCR5, SELP, CCR2, CTLA4, SDF1, VEGF, 
LTA, IL5RA, CD14, C5, UGB, SELE, IL10, IL4, TCF7, 
CSF2, IL13, IL9, TNF, IL6, NOS3, Hp, and IL4R]. That is, 
among these 16 interactions, 3 would be expected to be 
significant by chance alone. These 16 interactions intro-




EPF OR 95% CI
V1-V4-V11-V14-V15-V28-V29-V30-V49
TGGGGGAGC 0.174 1.711 [0.686, 4.270]
CGGAGCAGC 0.068 4.857 [0.216, 109]
TGGGGCAGC 0.139 1.619 [0.611, 4.291]
TGGGGGAGT 0.075 0.405 [0.122, 1.339]
TGGAAGAGC 0.068 0.270 [0.072, 1.014]
V16-V17-V23-V26
TCCT 0.438 2.163 [1.284, 3.643]
GCAC 0.031 5.505 [0.664, 45.655]
GCAT 0.128 1.835 [0.566, 2.995]
TTCT 0.050 2.359 [0.619, 8.997]
EPF, OR and 95% CI stand for the estimated population fre-
quency, odds ratio, and confidence interval at the level of 95% 
respectively.
Table 8. KEGG pathway information for the 20 genes which have been identified to potentially relate to the formation of collaterals
Environmental information processing: Signalling molecules and interaction
Cytokine-cytokine receptor interaction CCR2, CCR5, IL6, IL4, IL4R, IL13, CSF2, IL5RA, IL9, VEGF, IL10, TNF, LTA
Signal transduction: Wnt signalling pathway TCF7
Cell adhesion molecules for immune system CTLA4, SELE, SELP, VCAM1
Cellular processes: Immune system
Hematopoietic cell lineage IL6, IL4, TNF, CD14
Complement and coagulation cascades C5
Toll-like receptor signalling pathway TNF, IL6
Natural killer cell mediated cytotoxity TNF
T cell receptor signalling pathway CTLA4, IL4, IL10, TNF
Fc epsilon RI signalling pathway IL4, IL13, TNF
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duce an interaction network as depicted in  figure 2 . In-
terestingly, based on the KEGG and GO pathway data-
base (http://www.genome.ad.jp/kegg/pathway and http://
www.ebi.ac.uk/ego), 21 of these 24 genes were found to be 
involved in two biological processes, namely, the envi-
ronmental information processing and cell processes. In 
particular, [CCR2, CCR5, IL6, IL4, IL4R, IL13, CSF2,
IL5RA, IL9, VEGF, IL10, TNF, and LTA] participated in 
the cytokine-cytokine receptor interaction. See  table 8 
for details. However, after correction for the disbalance 
of smoking and multi-vessel disease, only 5 of the above 
16 interactions remain significant, where 9 genes were 
involved: [CCR5, VEGF, C5, UGB, IL4, TCF7, IL13, IL9, 
and CSF2]. This may have resulted from limited sample 
size. Nevertheless, our results are consistent with previ-
ous findings that collateral formation is mediated by 
TNF, IL6, VEGF, and CSF2 reported previously by
Schultz et al.  [26] , Rakhit et al.  [27] , and Hossmann et al. 
 [28] . This is also in agreement with a recently reported 
activation of the expression of ICAM1, another TNF/
NFkB-induced gene in patients with coronary collaterals 
 [26] . See  table 9 for more information on the medical im-
plications of these genes.  The further biological mecha-
nisms, by which these genes or SNPs might confer a bet-
ter capacity of forming collaterals, remain to be elucidat-
ed by more experiments.
 Similar to collateral formation, the pathogenesis of 
atherosclerosis is also known to contain an important in-
flammatory component, involving the recruitment and 
adhesion of circulating leukocytes, particular mono-
cytes, to injured or otherwise stimulated vascular endo-
thelium  [29, 30] . Thus, the findings in the present study 
imply that important genes or gene families may be 
shared by collateral formation and inflammatory disor-
ders such as diabetes, cardiovascular disease, and athero-
sclerosis  [29, 30] .
Table 9. Reported relevant medical implications of the candidate 
genes in this study
Reported relevant implications Genes
Atherosclerosis VCAM1 CD14 VEGF IL10 [34]
Stroke CSF2 TGFB1 [35]
Coronary artery disease SELE IL1A IL1B [37]
Myocardial infarction SELP CCR2 LTA TNF IL6 SDF1 [41]
Diabetes CTLA4 TCF7 VDR [44]
Aortic aneurysm CCR5 [45]
Arteriogenesis CSF2 VEGF [23]
Cardiovascular disease in diabetics Hp [46]
Vascular wall injury NOS2A [47]
                                                CCR2       SELP      SELE       IL10 
     VCAM1          CCR5         VEGF 
       IL5RA           LTA           NOS2A       TNF 
CTLA4         SDF1      GC        CSF2         TCF7
                                                                   IL4 
CD14 
    C5     UGB 
 IL6         NOS3  
     Hp         IL4R    
 IL13        IL9   
 Fig. 2. The interaction networks that may 
influence the formation of collaterals. 
Each connecting line indicates a relation 
between 2 polymorphisms: A dashed line 
between two genes shows the linkage dis-
equilibrium across two groups of patients; 
the solid line indicates a down-interaction; 
the long dashed line between two genes in-
dicates an up-interaction. 
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 Study Limitations and strengths 
 To appreciate these findings, some aspects of this 
study merit consideration. First, the presence of collat-
eral circulation was defined by using the dichotomized 
form of the Rentrop classification. This semi-quantita-
tive method assesses spontaneously visible collateral cir-
culation, and may not identify vessels  ! 100   m in diam-
eter or those recruitable upon coronary occlusion. More 
invasive methods to quantify recruitable collateral flow 
have been developed. However, spontaneously visible 
collateral arteries may prevent ischemia in 90% of pa-
tients upon subsequent coronary occlusion  [31] . The 
functional importance of large collateral vessels is under-
scored by the notion that collateral flow is exponentially 
related to vessel radius  [31] . Indeed, prognostic signifi-
cance of collaterals has been demonstrated using the 
semi-quantitative method in patients with established 
coronary artery disease  [31] .
 A second issue is the fact that, due to the small sample 
size, our selection of the combination of main effects of 
individual genes from the stepwise logistic regression is 
only marginally significant and might not be unique. 
There are other possible combinations of individual SNPs 
that can explain the variation between individuals. For 
example, we run the logistic regression on all SNPs and 
select these alleles and SNPs with the coefficient signifi-
cance levels less than 0.05. Then we did identify a slight-
ly different set of SNPs (IL1A, CCR2, IL5RA, GC, CD14, 
TCF7, LTC4S, VEGF, C5, SDF1, VDR, MCP1, SCYA11, 
NOS2A, and ICAM1) that significantly account for the 
variation in the data.
 Despite these limitations, we believe our study for
the first time provides a view on polymorphism-inter-
acting networks involved in the complex processes con-
tributing to collateral formation. Our study confirms 
that collateral formation may share a common set of dis-
ease-susceptibility genes with other inflammatory re-
sponse related disorders. These findings offer a ratio-
nale for a large scale association study on collateral for-
mation.
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